Safety of combined antidepressant drugs

Sargant, W
March 1971
British Medical Journal;3/6/1971, Vol. 1 Issue 5748, p555
Academic Journal
No abstract available.


Related Articles

  • Can a person with AIDS take antidepressants?. Cohan, Gary R. // Advocate;11/2/93, Issue 641, p34 

    Discusses the safety of consuming antidepressants in combination with other drugs such as AZT, ddC, Bacterium, Foscamet and Neupogen. Recommendation to prioritize antidepressant therapy; Need to focus on the quality of life over the medical statistics and treatment; Claim of the safety of the...

  • Antidepressant drug use in primary care: A record linkage study in Tayside, Scotland. MacDonald, T.M.; McMahon, A.D. // BMJ: British Medical Journal (International Edition);10/5/96, Vol. 313 Issue 7061, p860 

    Presents a study on the use and safety of antidepressant drugs in Tayside, Scotland, with reference to their labelled warnings. Commonly prescribed antidepressants; Adverse effects; Patterns in antidepressant prescribing.

  • FDA responds to accusations of suppressing safety study. Arnold, Matthew // Medical Marketing & Media;Jun2004, Vol. 39 Issue 6, p15 

    Reports on the decision of the U.S. Food and Drug Administration not to present a study by safety officer Andrew Mosholder on the suicide risk of antidepressants. Safety and efficacy of antidepressants.

  • Antidepressants and Insomnia. Zammit, Gary K. // Primary Psychiatry;May2008, Vol. 15 Issue 5, p61 

    Mood disorders and insomnia are often comorbid conditions, sharing a complex and bi-directional relationship. Complicating the situation, mood stabilizers can disrupt sleep in a variety of different ways depending on a drug's mechanism of action, dosage level, and timing of administration. The...

  • 'Atypical' Antidepressants in Overdose. Buckley, Nicholas A.; Faunce, Thomas A. // Drug Safety;Jun2003, Vol. 26 Issue 8, p539 

    Outlines a study published in the journal 'Drug Safety,' which found that tricyclic antidepressants appear to be associated with a greater risk of death in overdose than other antidepressant agents. Comparison of major features of the atypical antidepressants relevant to toxicity in overdose.

  • Clinically Significant Drug Interactions with Newer Antidepressants. Spina, Edoardo; Trifirô, Gianluca; Caraci, Filippo // CNS Drugs;2012, Vol. 26 Issue 1, p39 

    After the introduction of selective serotonin reuptake inhibitors (SSRIs), other newer antidepressants with different mechanisms of action have been introduced in clinical practice. Because antidepressants are commonly prescribed in combination with other medications used to treat co-morbid...

  • Depression: A quicker fix? Matthews, Susan // Glamour;Jul99, Vol. 97 Issue 7, p55 

    Discusses the effectiveness of antidepressants. Why talking may be more beneficial than drugs; Situations wherein talking therapy works best in combination with antidepressants.

  • New molecular entities.  // Formulary;Sep2004, Vol. 39 Issue 9, p428 

    Reports on the United States Food and Drug Administration's approval of antidepressant Duloxetine for the treatment of major depressive disorder. Efficacy; Safety; Dosing.

  • Seroxat set for further scrutiny.  // Pulse;7/14/2003, Vol. 63 Issue 28, p13 

    Focuses on the review of antidepressant Seroxat, following a safety alert on link of the drug with attempted suicide among young adults in Great Britain.

  • Antidepressant use common in diabetics.  // PharmacoEconomics & Outcomes News;1/8/2011, Issue 619, p9 

    The article discusses research on the use of antidepressants in patients with diabetes, by K. Maderbacka and colleagues, published in "Pharmacoepidemiology and Drug Safety."


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics